Technology
Health
Biotechnology

InVivo Therapeutics

$1.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (1.81%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NVIV and other stocks, options, ETFs, and crypto commission-free!

About

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of SCIs. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. Read More The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in 2005 and is headquartered in Cambridge, MA.

Employees
12
Headquarters
Cambridge, Massachusetts
Founded
2005
Market Cap
14.38M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
170.97K
High Today
$1.70
Low Today
$1.61
Open Price
$1.66
Volume
25.51K
52 Week High
$15.50
52 Week Low
$1.34

Collections

Technology
Health
Biotechnology
Medical
Therapy
2015 IPO
US
North America

Earnings

-$3.34
-$2.27
-$1.20
-$0.13
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.34 per share
Actual
Expected Mar 25, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.